CellType
PrivateLast Round
Seed
Mar 1, 2026
Total Funding Raised
$1M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
CellType is a life sciences and artificial intelligence company that has developed a biological reasoning engine to simulate drug responses in human biology.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Medical AI, Healthcare Analytics, ML Platforms
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Foundation
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
CellType Comparables
Compare CellType with similar companies based on industry and business-model similarity.
CellType Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Mar 1, 2026 | ||||
| Seed | Feb 1, 2026 | ||||
| Seed | Jan 1, 2026 |
CellType Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Pioneer Fund | Seed |
| Founder Factor | Seed |
| Y Combinator | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 25, 2026
Grew 100% QoQ from 3 to 6 employees.
- Jun 21, 2026
Monthly visitors grew 100% MoM, reaching 6.8K.
CellType Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about CellType's valuation, stock price, and market status.
Is CellType a public or private company?
CellType is a private company.
What is the current stock price of CellType?
CellType is a private company with no public stock price. No recent secondary market data is available.
How much is CellType worth (valuation)?
Valuation information for CellType is not publicly available.
Can I buy CellType stock?
CellType shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was CellType's last funding round?
CellType's most recent funding round was Seed on January 1, 2026.
Who are the main investors in CellType?
Key investors in CellType include Y Combinator.
Will CellType IPO soon?
No public IPO plans have been announced for CellType.
How can I track CellType secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor CellType's secondary market activity and sign up for updates.